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Abstract: Background: Primary iron overload in African Americans has
been reported predominantly from autopsy studies. Methods: We char-
acterized hepatic iron phenotypes in 83 African Americans who
underwent liver biopsy during the interval 1990 to 1995. We tabulated
pathology report form data, iron grades in hepatocytes (0–4) and Kupffer
cells (0–3) and abnormal liver histology. Increased iron was deﬁned as
hepatocyte or Kupffer iron grades $2, respectively. Heavy iron was
deﬁned as hepatocyte iron grade 3 or 4. Primary iron overload was
deﬁned as the presence of grade 3 or 4 hepatocellular iron in the absence
of evidence of chronic alcohol effect, viral hepatitis, steatosis, unex-
plained inﬂammation, chronic erythrocyte transfusion or chronic ingestion
of iron supplements. Results: There were 37 men and 46 women (mean
age: 53 6 15 [SD] years). We observed heavy ethanol consumption,
12.0%; viral hepatitis, 26.5%; steatosis without heavy ethanol consump-
tion, 43.4%; inﬂammation, 45.6%; ﬁbrosis, 26.2% and bridging ﬁbrosis/
cirrhosis, 29.4%. Logistic regression on bridging ﬁbrosis/cirrhosis re-
vealed positive associations with heavy ethanol consumption (P 5
0.0410) and viral hepatitis (P 5 0.0044). The 22 patients (26.5%) with
increased iron had greater mean age, proportion of men and heavy ethanol
consumption. Five patients had heavy iron staining, among whom were 3
women (mean age: 54 years) with primary iron overload. Two of the 3
women had cirrhosis and diabetes mellitus. Conclusions: Among 83 adult
African Americans who underwent liver biopsy, 3.6% had hepatic iron
phenotypes consistent with primary iron overload.
Key Indexing Terms: African Americans; Hemochromatosis; Hepato-
cyte; Iron overload; Liver. [Am J Med Sci 2015;349(1):50–55.]
BACKGROUND
P rimary iron overload in African Americans is a heterogeneousgroup of disorders. DNA analysis as an aid to diagnosis of some
primary iron overload disorders became possible after the discovery
of the HFE gene (chromosome 6p21.3) in 1996.1 In whites, for
example, HFE genotypes, especially p.C282Y homozygosity,
account for approximately 90% of hemochromatosis phenotypes.1,2
In contrast, hemochromatosis-associated HFE genotypes are
uncommon in African Americans with high-iron phenotypes.3,4
Deleterious mutations in non-HFE iron-related genes have been
described in few African Americans with primary iron overload
unassociated with anemia.5–7 Population screening to identify pri-
mary iron overload in African Americans has been performed using
an elevated transferrin saturation or serum ferritin criterion like that
used in screening whites.4,8 The prevalence of possible or con-
ﬁrmed cases was very low4,8 in part because mean transferrin
saturation is lower and mean serum ferritin is higher in African
Americans than whites.4 Thus, the pretreatment diagnosis of pri-
mary iron overload in African Americans depends predominantly
on demonstration of high-iron phenotypes detectable in the liver.
Grading stainable iron in hepatocytes and Kupffer cells is
a basic hepatic iron phenotyping method. There is a signiﬁcant
positive correlation of hepatocyte iron grade with hepatic iron
concentration (HIC) measured using atomic absorption spec-
trometry.9 The hepatic iron index (HII) is HIC adjusted by age
(mmol Fe/g dry weight/y).10,11 HII $1.9 conﬁrms the diagnosis
of iron overload and has been used as a diagnostic criterion of
primary iron overload in African Americans.12,13
Most high-iron phenotypes in African Americans with-
out anemia have been communicated as case reports,3,14,15 small
case series12,13 or autopsy studies.13,16–18 We performed a retro-
spective study of consecutive diagnostic liver biopsy specimens
of African American adults in a large suburban medical center
in central Alabama during the interval 1990 to 1994, a period
during which DNA-based diagnosis of primary iron overload
disorders was not available. We identiﬁed and characterized
hepatic iron phenotypes using hepatocyte and Kupffer cell iron
grades. We discuss our results in the context of the overall
prevalence of high-iron phenotypes in African Americans and
acquired factors that may contribute to their development.
METHODS
Selection of Study Subjects
The performance of this study was approved by the
Institutional Review Board of Brookwood Medical Center. We
performed a computerized and manual search of the database of
the Medical Center’s surgical pathology department to identify
all pathology report forms of liver specimens obtained by per-
cutaneous or intraoperative biopsy from adults (age $18 years)
during the 5-year study interval 1990 to 1994. Thereafter, we
selected patients whose pathology report forms identiﬁed them
as either African American or black. One hundred African
Americans underwent liver biopsy during the study interval.
We retrieved their liver biopsy slides and tabulated the succinct
demographic data, clinical history and pathologist’s interpreta-
tion of the biopsies. Using hospital or clinic charts or blood
bank records was not part of the present study.
Performance of Liver Biopsies
Liver specimens were obtained by biopsy as part of
routine medical care. No biopsy specimen was obtained as
a sequel to population or family screening to detect iron overload
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phenotypes. Radiologists or gastroenterologists obtained speci-
mens using percutaneous technique, 18-gauge needles and
ultrasound or CT guidance. Surgeons obtained specimens during
open cholecystectomy or other intraperitoneal operations.
Selection of Evaluable Liver Biopsy Specimens
We excluded biopsy specimens less than 10 mm long.
Thus, the specimen of 1 woman was inevaluable because there
was insufﬁcient liver for interpretation. We excluded 15 other
cases because the biopsies were performed to conﬁrm the
diagnosis of malignancy and not to evaluate parenchymal liver
disease. Furthermore, none of these biopsy specimens had
sufﬁcient liver parenchyma for analysis. The biopsy specimen
of 1 man was excluded because his pathology report indicated
that he had transfusion iron overload consequent to treatment
for acute leukemia. Altogether, there were 83 specimens
evaluable for the present analyses.
Histology Technique
Liver specimens were ﬁxed in 10% neutral buffered
formalin. Triplicate sections of parafﬁn-embedded liver were
routinely prepared. One section was stained with hematoxylin
and eosin, another with Perls’ acid ferrocyanide technique to
demonstrate nonheme ferric iron and a third with Masson’s
trichrome technique to assess collagen ﬁbrosis. In some cases,
reticulin stains were also used to assess ﬁbrosis. Other special
stains were used in some cases, as appropriate. Appropriate
positive and negative control specimens were prepared and
reviewed with each staining batch.
Liver Morphology
Interpretation of liver histology reported herein repre-
sents consensus opinions of the surgical pathologist and at least
2 of the authors. Steatosis unassociated with excessive ethanol
consumption, inﬂammation and bridging ﬁbrosis/cirrhosis was
assessed as described elsewhere.19 The abnormality was graded
as absent or present. The presence or absence of ﬁbrosis, bridg-
ing ﬁbrosis or hepatic cirrhosis was determined using Masson’s
trichrome-stained specimens with or without reticulin stains as
described previously.19 Fibrosis without bridging or cirrhosis
was graded as either present or absent. We deﬁned that bridging
ﬁbrosis and cirrhosis were equivalent; their presence or absence
was analyzed as a dichotomous variable. The presence of
abnormalities characteristic of viral hepatitis was based on
a combination of information obtained from pathology request
forms and histologic features of the biopsy specimens.
Iron Grading
All slides were reviewed by a surgical pathologist and at
least 2 of the authors. The iron grades in each case represent
consensus opinions. Hepatocellular iron was graded according
to these criteria: grade 0—no visible iron; grade 1—iron visible
in very few hepatocytes; grade 2—iron visible in 5% to 10% of
hepatocytes; grade 3—iron visible in $40% of hepatocytes and
grade 4—abundant iron visible in most hepatocytes.12 Kupffer
cell iron was graded according to these criteria: grade 0—no
visible iron in Kupffer cells; grade 1—iron visible in $one-
third of Kupffer cells; grade 2—iron visible in one-third to
#two-thirds of Kupffer cells and grade 3—abundant iron vis-
ible in more than two-thirds of Kupffer cells.12 Hepatocyte or
Kupffer cell iron of grade 0 or 1 was deﬁned as normal.
Increased iron was deﬁned as hepatocyte and/or Kupffer
cell iron grade $2.12 Heavy iron staining was deﬁned as hepa-
tocyte iron grade 3 or 4, regardless of Kupffer cell iron grade.
Primary iron overload was deﬁned as the presence of grade
3 or 4 hepatocellular iron in the absence of evidence of chronic
alcohol effect, viral hepatitis, steatosis, unexplained inﬂamma-
tion, chronic erythrocyte transfusion or chronic ingestion of
iron supplements.
Hepatic Iron Concentration
The reference range for HIC measured by atomic
absorption spectrometry is 200 to 2400 mg Fe/g dry weight
(3.6–43.0 mmol Fe/g dry weight). In only 1 patient was the
HIC measurement requested by the interpreting pathologist
and displayed in the report form. Measuring HIC on the biopsy
specimens as an addendum to the data on pathology report
forms was beyond the scope of the present study.
Other Conditions
These were tabulated from information on the pathology
request forms and included the following: reports of heavy
ethanol consumption (usually not otherwise speciﬁed), positive
serologic reactions or quantitative or qualitative RNA assessments
for viral hepatitis B or C, elevated blood iron measures (deﬁned as
serum iron concentration, transferrin saturation or serum ferritin
concentration), history of erythrocyte transfusion, consumption of
iron supplements, numbers of pregnancies and histories of
thalassemia and other heritable or acquired types of anemia.
Some conditions we tabulated were taken from the pathologist’s
histologic interpretations of the liver biopsy specimens.
Statistical Analyses
The present data set consisted of observations in 83
consecutive adult African Americans whose liver biopsy speci-
mens were evaluable. Analyses were performed with a computer
spreadsheet (Excel 2000; Microsoft Corp, Redmond, WA) and
a statistical program (GB-Stat version 10.0, 2003; Dynamic
Microsystems, Inc, Silver Spring, MD). Descriptive data are
displayed as enumerations, percentages and mean 6 1 SD. Fre-
quency values were compared using Pearson’s x2 analysis or
Fisher’s exact test, as appropriate. Mean values were compared
using 1-tailed student t-test. Some data were analyzed using
Pearson’s correlation coefﬁcient. We performed logistic regres-
sions on increased stainable iron and cirrhosis. All independent
variables except age (continuous variable) were dichotomous.
Values of P , 0.05 were deﬁned as signiﬁcant.
RESULTS
General Characteristics of 83 Patients
There were 37 men (44.6%) and 46 women (55.4%)
(Table 1). Liver biopsy was performed using percutaneous tech-
nique in 64 patients (77.1%) and intraoperative technique in the
remaining 19 patients (22.9%). The mean ages of men and
women were similar (52 6 16 years and 54 6 14 years, respec-
tively; P 5 0.5201). There were reports of heavy ethanol con-
sumption in 10 patients (12.0%), viral hepatitis in 18 patients
(26.5%), steatosis unassociated with a report of heavy ethanol
consumption in 36 patients (43.4%), inﬂammation in 31 patients
(45.6%), ﬁbrosis in 16 patients (26.2%) and bridging ﬁbrosis/
cirrhosis in 20 patients (29.4%) (Table 1). Elevated blood iron
measures were reported in 4 patients (4.8%). No patient had
a history of anemia treated with erythrocyte transfusion.
Comparisons of Patients With and Without
Increased Stainable Liver Iron
Twenty-two patients (26.5%) had increased stainable iron
(Table 1). Their mean age, the proportion of men and the reports
of heavy ethanol consumption were greater than in patients
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without increased stainable iron. The proportion of patients with
steatosis unassociated with increased ethanol consumption was
lower among those with increased stainable iron than among
those without increased stainable iron (Table 1). The proportions
of patients with and without increased stainable iron who had
reports of increased blood iron measures or who underwent per-
cutaneous biopsy did not differ signiﬁcantly (Table 1).
Characteristics of 22 Patients With Increased
Stainable Iron
There were 15 men (68.2%) and 7 women (31.8%). The
proportions of men and women with increased stainable iron in
hepatocytes or Kupffer cells did not differ signiﬁcantly. Four
patients had increased hepatocyte staining only (18.2%) and 6
patients (27.3%) had increased Kupffer cell staining only.
Twelve patients (54.5%) had a mixed pattern of increased
hepatocyte and Kupffer cell iron staining. Elevated blood iron
measures were reported in 2 patients (9.1%). Analysis of
hepatocyte and Kupffer cell iron grades revealed a Pearson
correlation coefﬁcient of 0.2260 (P 5 0.3120).
Characteristics of 5 Patients With Heavy
Iron Staining
Heavy iron staining was observed in 1 of 37 men (2.7%)
and 4 of 46 women (8.7%) (P 5 0.4471). The mean age of
these 5 probands was 60 years (Table 2). Four of these patients
underwent percutaneous biopsy. None had a prebiopsy report of
elevated blood iron measures. Each had a mixed pattern of
heavy staining in both hepatocytes and Kupffer cells (Table 2).
None had reports of heavy ethanol consumption or histologic
evidence of hepatic steatosis (Table 2).
A 73-year-old woman had viral hepatitis without report
of another abnormality. A 66-year-old man had cirrhosis and
hepatic inﬂammation without report of another abnormality.
Three women had primary iron overload as deﬁned
herein. Their mean age was 54 years. Two of the 3 women had
cirrhosis and diabetes mellitus (Table 2).
Logistic Regressions on Increased Stainable Iron
and Cirrhosis
Regression on increased stainable iron was performed
using age, sex, heavy ethanol consumption, viral hepatitis,
steatosis, inﬂammation, ﬁbrosis, bridging ﬁbrosis/cirrhosis and
thalassemia observations from all 83 evaluable patients as
independent variables. There was no signiﬁcant association of
any of these independent variables with increased stainable
iron. We performed a regression on cirrhosis using age, sex,
increased stainable iron, heavy ethanol consumption, viral
hepatitis, steatosis, inﬂammation, ﬁbrosis, bridging ﬁbrosis/
cirrhosis and thalassemia as independent variables. Bridging
ﬁbrosis/cirrhosis was positively associated with heavy ethanol
consumption (P 5 0.0410) and viral hepatitis (P 5 0.0044).
TABLE 1. Characteristics of 83 African Americans who underwent liver biopsy
Characteristics
Increased stainable
iron (n 5 22)
No increased stainable
iron (n 5 61) P
Mean age 6 1 SD, y 58 6 16 51 6 16 0.0304
Men, % (n) 68.2 (15) 36.1 (22) 0.0094
Heavy ethanol, % (n) 31.8 (7) 4.9 (3) 0.0028
Viral hepatitis, % (n)a 22.7 (5) 21.3 (13) 0.5540
Steatosis, % (n)b 22.7 (5) 50.8 (31) 0.0226
Inﬂammation, % (n)b 31.8 (7) 39.3 (24) 0.5316
Fibrosis, % (n)b 13.6 (3) 21.3 (13) 0.3301
Cirrhosis, % (n)b 31.8 (7) 21.3 (13) 0.3232
Elevated blood iron measures, n (%)c 9.1 (2) 3.3 (2) 0.2695
Thalassemia, % (n) 9.1 (2)d 0.0 (0) 0.0679
Percutaneous biopsy technique, % (n) 90.9 (20) 0.0 (0) 0.0679
a Deﬁned as hepatitis C by clinical history or hepatic histology on pathology reports except hepatitis B in 1 patient.
b Steatosis, inﬂammation, and ﬁbrosis were assessed as described in detail elsewhere.19 Cirrhosis includes bridging ﬁbrosis, by deﬁnition. These
abnormalities were graded as present or absent.
c Reports of increased serum iron, transferrin saturation or serum ferritin levels.
d A 63-year-old man had reports of alpha-thalassemia trait, heavy ethanol consumption, cirrhosis, liver iron concentration 3596 mg/g dry weight
and HII 1.0. A 43 year-old woman had reports of beta-thalassemia trait, cirrhosis, diabetes mellitus, and hypopituitarism.
TABLE 2. Five African Americans with heavy liver iron staininga
Age (y), sex Hepatocyte iron grade Kupffer cell iron grade Viral hepatitis Inﬂammation Cirrhosisb
43 Fc 3 2 0 0 +
44 F 3 3 0 0 0
66 M 3 2 0 + +
73 F 3 2 + 0 0
76 Fd 4 3 0 0 +
a Heavy iron staining was deﬁned as hepatocyte iron grade of 3 or 4, regardless of Kupffer cell iron grade. None of these patients had heavy
ethanol consumption or hepatic steatosis or ﬁbrosis.
b Includes bridging ﬁbrosis, by deﬁnition.
c This woman had reports of beta-thalassemia trait, diabetes mellitus and hypopituitarism.
d This woman had diabetes mellitus.
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DISCUSSION
We observed primary iron overload in 3 of the present 83
African American adults (3.6%) who underwent liver biopsy. All
were women (mean age: 54 years). Two of the 3 women had
cirrhosis and diabetes mellitus. None of these 3 women had
chronic ethanol consumption, evidence of viral hepatitis, stea-
tosis, unexplained hepatic inﬂammation or reports of previous
erythrocyte transfusion or consumption of iron supplements.
We chose the study interval 1990 to 1994 because iron
overload diagnosis at that time depended exclusively on iron
phenotyping. In a 1996 study, 4 of 326 African American adults
(1.2%) who died in hospital and underwent autopsy had
HII $1.9 (1.9–5.6), after adjustment for erythrocyte transfu-
sions.13 There were 2 men and 2 women (mean age: 56 years).
Wurapa et al13 concluded that these 4 patients had primary iron
overload. Among 4,573 African American adults in a large uni-
versity hospital autopsy series, 7 (0.15%) had severe multiorgan
iron overload unassociated with erythrocyte transfusion.17 Six of
the 7 patients had clinical histories and pathologic ﬁndings
typical of primary African American iron overload, and the other
patient had a clinical and pathologic picture consistent with early
age-of-onset (juvenile) hemochromatosis.17
There is a signiﬁcant positive correlation of hepatocyte iron
grades with HIC in subjects in whom the clinical manifestations and
histologic distribution of hepatic iron suggest hemochromatosis, that
is, predominance of hepatocyte iron and no apparent explanation for
iron overload.20 HII was conceived and validated as an aid to the
diagnosis of hemochromatosis homozygosity in whites10,11 before
mutation analysis for pathogenic HFE alleles became possible in
1996.1 In whites, HII $1.9 is sufﬁciently high to conﬁrm the
diagnosis of hemochromatosis homozygosity and exclude lesser
degrees of HIC for age, that is, typically associated with heavy
ethanol consumption or hemochromatosis heterozygosity.10,11 HII
has also been used as a conservative surrogate diagnostic criterion
for primary iron overload in African Americans3,12,13,16 and other
types of nonhemochromatosis hepatic or systemic iron overload.21,22
Measuring HII was beyond the scope of the present work.
Elevated blood iron measures were not mentioned on the
pathology report forms of any of the 3 present women who had
primary iron overload as deﬁned herein. Clinicians treating
most of the present patients may not have considered primary
iron overload as a possible cause of liver disease because few
cases of primary iron overload in African Americans were
reported before 1995.14,15 In a survey of 2,563 physicians in the
United States published in 2002, only 32% reported correct
answers about diagnosis of hemochromatosis,23 although hemo-
chromatosis in whites was well described in the U.S. literature
before 1990.24–27 It is also possible that assessments of blood
iron measures performed before liver biopsy in some of the
patients were not reported on their pathology request forms.
The prevalence of increased liver iron staining was
greater in men than women in the present study. In 341 African
Americans who underwent coroner’s autopsy, there was a sig-
niﬁcant correlation of male sex with hepatocyte iron grade.17
Higher testosterone levels in men could downregulate hepcidin,
resulting in greater iron absorption and iron stores in men than
in women.28 The iron losses of menstruation, pregnancy and
lactation could also account for lower iron stores in women than
men, on the average. Nonetheless, documentation of voluntary
blood donation, reports of medications or illnesses that cause
blood loss or that would impair iron absorption and reports of
iron supplements, numbers of pregnancies and access to blood
bank records of erythrocyte transfusion were not available for
the present analyses.
The prevalence of heavy ethanol consumption reports was
greater in the present patients with increased liver iron staining,
consistent with observations in cohorts of African Americans with
nontransfusion iron overload.12,13 Logistic regressions on cirrhosis
revealed positive associations with reports of heavy ethanol con-
sumption. Heavy ethanol consumption downregulates hepcidin
and thus could contribute to increased iron absorption.29 Chronic
alcoholism is a common cause of cirrhosis in North America. In
persons with cirrhosis, regardless of cause, serum hepcidin levels
are lower. This is presumed to reﬂect dysregulation of iron sens-
ing and decreased hepcidin production by cirrhotic livers.30
More than one-ﬁfth of the present patients had evidence
of chronic viral hepatitis, mostly hepatitis C. There may have
been a selection bias to perform liver biopsy in patients who
had proven or suspected chronic viral hepatitis. A greater
proportion of African Americans than persons of other races
respond to chronic hepatitis C infection with an increase in iron
stores, after adjustment for age, alcohol intake, gender,
menopausal status, education, body mass index and poverty
index.31 Regardless, the proportions of the present patients with
viral hepatitis did not differ signiﬁcantly between those with
and those without increased liver iron staining. Logistic regres-
sions on cirrhosis revealed positive associations with viral hep-
atitis in the present cohort. Chronic viral hepatitis is a common
cause of cirrhosis in North America.
Hepatic steatosis unassociated with reports of heavy
ethanol consumption was present in 43% of the present 83
patients. Our prevalence estimate may have been high because
we did not stratify patients by severity of steatosis or may have
been low because some patients with steatosis had heavy
ethanol consumption unreported on pathology request forms. In
another study of liver biopsies, 18% of 301 African Americans
without histories of increased ethanol consumption had hepatic
steatosis grade 1, 2, 3 or 4.32
Hepatic steatosis or increased body mass index may
promote iron deposition in the liver.33,34 Hepatic iron sensing is
abnormal in nonalcoholic fatty liver disease but hepcidin pro-
duction is increased.35,36 Increased hepatic iron retention may
be due to decreased ferroportin expression in hepatocytes and
consequent decreased iron export.35 In addition, increased
hepatic iron may act in concert with steatosis to promote liver
injury.33,34,37 In 30 African American adults discovered to have
heavy hepatic iron staining at coroner’s autopsy, there were
signiﬁcant positive correlations of steatosis with inﬂammation
and of inﬂammation with bridging ﬁbrosis/cirrhosis.17 In the
present study, steatosis was not associated with increased iron
staining in univariable analyses or with cirrhosis in regression
analyses. Steatosis was not observed in any of the 3 present
patients with HII $1.9. Similarly, nonalcoholic steatosis dem-
onstrated by liver biopsy or ultrasonography/computerized
tomography scan criteria in white hemochromatosis probands
with HFE C282Y homozygosity was not a predictor of iron
overload measured by quantitative phlebotomy.38
Erythrocyte transfusion is an unlikely cause of iron
overload in the present 83 patients. Among the 100 patients
whose pathology reports we initially reviewed, 1 man was
excluded because he had a report of transfusion iron overload
associated with treatment of acute myelogenous leukemia. It
was reported that 2 of the evaluable 83 patients had minor types
of thalassemia. Erythrocyte transfusion is not routinely admin-
istered in such patients because anemia, if any, is mild.
Although erythropoiesis is mildly ineffective in minor types
of thalassemia, iron absorption is not increased to the extent that
iron overload occurs39 except in some patients who have in-
herited other iron overload-related alleles.2,40
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There are other uncertainties in the present results. The
criteria used by physicians and surgeons to advise their patients
to undergo liver biopsy were probably variable and may have
led to selection bias in the present cohort. The number of
African Americans believed to have nontransfusion iron over-
load at our medical center during the interval 1990 to 1994 but
who did not undergo liver biopsy is unknown. Some African
Americans with primary iron overload reported previously had
malignancy.12,13 We excluded 15 patients from the present anal-
yses because their liver biopsies contained cancer, but there was
insufﬁcient liver parenchyma for evaluation of iron staining and
liver histology. It is unknown if any of these patients had
increased liver iron. Physicians practicing in this geographic
area today may be more familiar with iron overload in African
Americans than they were in the interval 1990 to 1994, although
this is unproven. Some African Americans previously reported
to have had iron overload by quantitative phlebotomy criteria
had normal HIC and HII,1.9.12 This implies that other patients
in the present cohort may have primary iron overload that was
undetected by the methods used in this study. HIC measure-
ments, if performed in all of the present cases, would have
provided more information about HII in African Americans.
Nonetheless, it is unlikely that having such measurements
would have changed our estimation of the proportion of patients
who had heavy iron staining deﬁned herein as primary iron
overload. The occurrence of common HFE missense mutations
or deleterious mutations in non-HFE genes and family history
of disease in the present patients is unknown.
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